Motavizumab - New Biological Therapy for RSV Prevention

Print-Icon
Print

MedImmune's motavizumab is a monoclonal antibody for prevention of RSV infection, a common respiratory tract infection in babies and infants.
 
Next»

Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development